NOVAVAX INC (NVAX) Gross profit 2020–2025
NOVAVAX INC (NVAX) annual gross profit history from SEC filings — each fiscal year as reported.
$1.1BFY2025 · since FY2020: $475.6M → $1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1B | +119.1% |
| FY2024 | $479.4M | -25.1% |
| FY2023 | $639.9M | -40.7% |
| FY2022 | $1.1B | -5.8% |
| FY2021 | $1.1B | +141.0% |
| FY2020 | $475.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NVAX financial trends
NVAX RevenueNVAX Net incomeNVAX Net marginNVAX Gross marginNVAX Operating incomeNVAX Operating marginNVAX Operating cash flowNVAX Free cash flowNVAX Capital expendituresNVAX Return on equityNVAX Stock buybacksNVAX Dividends paidNVAX Total assetsNVAX Total liabilitiesNVAX Shareholders’ equityNVAX overview →